Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice

Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice

Recurrent locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) is associated with dismal prognosis because of its highly invasive behavior and resistance to conventional intensive chemotherapy. The combination of targeted therapy and conventional chemotherapy has significantl...

Full description

Bibliographic Details
Main Authors: Hui-Ching Wang, Tsung-Jang Yeh, Leong-Perng Chan, Chin-Mu Hsu, Shih-Feng Cho
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:International Journal of Molecular Sciences
Subjects:
head and neck cancer
immunotherapy
immune checkpoint inhibitor
biomarker
Online Access:https://www.mdpi.com/1422-0067/21/20/7621

Internet

https://www.mdpi.com/1422-0067/21/20/7621

Similar Items